Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer

DNA Repair

Volumn 9, Issue 5, 2010, Pages 558-566

  Zhang, Zhengdong ^a   Wang, Luo ^a   Wei, Sheng ^a   Liu, Zhensheng ^a   Wang, Li E ^a   Sturgis, Erich M ^a   Wei, Qingyi ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

DNA repair; Genetic susceptibility; Methylation; Molecular epidemiology; Oral cancer

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; OROPHARYNX CANCER; PRIORITY JOURNAL; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DNA MODIFICATION METHYLASES; DNA REPAIR; DNA REPAIR ENZYMES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 77952103745     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2010.02.006     Document Type: Article

References (46)

1. Parkin D.M., Pisani P., and Ferlay J. Global cancer statistics. CA Cancer J. Clin. 49 (1999) 33-64
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., and Thun M.J. Cancer statistics, 2009. CA Cancer J. Clin. 59 (2009) 225-249
3. Blot W.J., McLaughlin J.K., Winn D.M., Austin D.F., Greenberg R.S., Preston-Martin S., Bernstein L., Schoenberg J.B., Stemhagen A., and Fraumeni Jr. J.F. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 48 (1988) 3282-3287
4. Pegg A.E., and Byers T.L. Repair of DNA containing O6-alkylguanine. Faseb J. 6 (1992) 2302-2310
5. Kaina B., Christmann M., Naumann S., and Roos W.P. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst) 6 (2007) 1079-1099
6. Aquilina G., Biondo R., Dogliotti E., Meuth M., and Bignami M. Expression of the endogenous O6-methylguanine-DNA-methyltransferase protects Chinese hamster ovary cells from spontaneous G:C to A:T transitions. Cancer Res. 52 (1992) 6471-6475
7. Pegg A.E., Dolan M.E., and Moschel R.C. Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog. Nucleic Acid Res. Mol. Biol. 51 (1995) 167-223
8. Preuss I., Haas S., Eichhorn U., Eberhagen I., Kaufmann M., Beck T., Eibl R.H., Dall P., Bauknecht T., Hengstler J., Wittig B.M., Dippold W., and Kaina B. Activity of the DNA repair protein O6-methylguanine-DNA methyltransferase in human tumor and corresponding normal tissue. Cancer Detect Prev. 20 (1996) 130-136
9. Hengstler J.G., Tanner B., Moller L., Meinert R., and Kaina B. Activity of O(6)-methylguanine-DNA methyltransferase in relation to p53 status and therapeutic response in ovarian cancer. Int. J. Cancer 84 (1999) 388-395
10. Sharma S., Salehi F., Scheithauer B.W., Rotondo F., Syro L.V., and Kovacs K. Role of MGMT in tumor development, progression, diagnosis, treatment and prognosis. Anticancer Res. 29 (2009) 3759-3768
11. Esteller M., Hamilton S.R., Burger P.C., Baylin S.B., and Herman J.G. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 59 (1999) 793-797
12. Skorpen F., and Krokan H.E. The methylation status of the gene for O6-methylguanine-DNA methyltransferase in human Mer+ and Mer- cells. Carcinogenesis 16 (1995) 1857-1863
13. Jacinto F.V., and Esteller M. MGMT hypermethylation: a prognostic foe, a predictive friend. DNA Repair (Amst) 6 (2007) 1155-1160
14. Rosas S.L., Koch W., da Costa Carvalho M.G., Wu L., Califano J., Westra W., Jen J., and Sidransky D. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 61 (2001) 939-942
15. Zuo C., Ai L., Ratliff P., Suen J.Y., Hanna E., Brent T.P., and Fan C.Y. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 967-975
16. Maruya S., Issa J.P., Weber R.S., Rosenthal D.I., Haviland J.C., Lotan R., and El-Naggar A.K. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin. Cancer Res. 10 (2004) 3825-3830
17. Puri S.K., Si L., Fan C.Y., and Hanna E. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am. J. Otolaryngol. 26 (2005) 12-17
18. Dikshit R.P., Gillio-Tos A., Brennan P., De Marco L., Fiano V., Martinez-Penuela J.M., Boffetta P., and Merletti F. Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers. Cancer 110 (2007) 1745-1751
19. Martone T., Gillio-Tos A., De Marco L., Fiano V., Maule M., Cavalot A., Garzaro M., Merletti F., and Cortesina G. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin. Cancer Res. 13 (2007) 5089-5094
20. Iwakuma T., Sakumi K., Nakatsuru Y., Kawate H., Igarashi H., Shiraishi A., Tsuzuki T., Ishikawa T., and Sekiguchi M. High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase. Carcinogenesis 18 (1997) 1631-1635
21. Rodriguez M.J., Acha A., Ruesga M.T., Rodriguez C., Rivera J.M., and Aguirre J.M. Loss of expression of DNA repair enzyme MGMT in oral leukoplakia and early oral squamous cell carcinoma. A prognostic tool?. Cancer Lett. 245 (2007) 263-268
22. Shaw R.J., Hall G.L., Lowe D., Liloglou T., Field J.K., Sloan P., and Risk J.M. The role of pyrosequencing in head and neck cancer epigenetics: correlation of quantitative methylation data with gene expression. Arch. Otolaryngol. Head Neck Surg. 134 (2008) 251-256
23. Sawhney M., Rohatgi N., Kaur J., Gupta S.D., Deo S.V., Shukla N.K., and Ralhan R. MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis. Oral Oncol. 43 (2007) 515-522
24. Rydberg B., Spurr N., and Karran P. cDNA cloning and chromosomal assignment of the human O6-methylguanine-DNA methyltransferase: cDNA expression in Escherichia coli and gene expression in human cells. J. Biol. Chem. 265 (1990) 9563-9569
25. Natarajan A.T., Vermeulen S., Darroudi F., Valentine M.B., Brent T.P., Mitra S., and Tano K. Chromosomal localization of human O6-methylguanine-DNA methyltransferase (MGMT) gene by in situ hybridization. Mutagenesis 7 (1992) 83-85
26. Otsuka M., Abe M., Nakabeppu Y., Sekiguchi M., and Suzuki T. Polymorphism in the human O6-methylguanine-DNA methyltransferase gene detected by PCR-SSCP analysis. Pharmacogenetics 6 (1996) 361-363
27. Egyhazi S., Ma S., Smoczynski K., Hansson J., Platz A., and Ringborg U. Novel O6-methylguanine-DNA methyltransferase SNPs: a frequency comparison of patients with familial melanoma and healthy individuals in Sweden. Hum. Mutat. 20 (2002) 408-409
28. 6-alkylguanine-DNA alkyltransferase. DNA Repair (Amst) 6 (2007) 1071-1078
29. Bugni J.M., Han J., Tsai M.S., Hunter D.J., and Samson L.D. Genetic association and functional studies of major polymorphic variants of MGMT. DNA Repair (Amst) 6 (2007) 1116-1126
30. Povey A.C., Margison G.P., and Santibanez-Koref M.F. Lung cancer risk and variation in MGMT activity and sequence. DNA Repair (Amst) 6 (2007) 1134-1144
31. Deng C., Xie D., Capasso H., Zhao Y., Wang L.D., and Hong J.Y. Genetic polymorphism of human O6-alkylguanine-DNA alkyltransferase: identification of a missense variation in the active site region. Pharmacogenetics 9 (1999) 81-87
32. Ma S., Egyhazi S., Ueno T., Lindholm C., Kreklau E.L., Stierner U., Ringborg U., and Hansson J. O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma. Br. J. Cancer. 89 (2003) 1517-1523
33. Liu R., and Zhuang Z. Single-nucleotide polymorphisms of human O6-methylguanine-DNA methyltransferase (MGMT) gene in lung cnacer patients from south China. J. Health Toxicol. 16 (2002) 1-5
34. Liu R., Zhuang Z., He C., and He Y. Relationship between genetic polymorphisms of human O6-methylguanine-DNA methyltransferase (MGMT) gene and susceptibility to tumors. Carcinog. Teratog. Mutag. 14 (2002) 101-106
35. Wang L., Liu H., Zhang Z., Spitz M.R., and Wei Q. Association of genetic variants of O6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic Whites. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 2364-2369
36. Hu Z., Wang H., Shao M., Jin G., Sun W., Wang Y., Liu H., Wang Y., Ma H., Qian J., Jin L., Wei Q., Lu D., Huang W., and Shen H. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis. Hum. Mutat. 28 (2007) 431-440
37. Huang W.Y., Olshan A.F., Schwartz S.M., Berndt S.I., Chen C., Llaca V., Chanock S.J., Fraumeni Jr. J.F., and Hayes R.B. Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1747-1753
38. Li C., Liu J., Li A., Qian L., Wang X., Wei Q., Zhou J., and Zhang Z. Exon 3 polymorphisms and haplotypes of O(6)-methylguanine-DNA methyltransferase and risk of bladder cancer in southern China: a case-control analysis. Cancer Lett. 227 (2005) 49-57
39. Zhang Z., Shi Q., Sturgis E.M., Spitz M.R., Hong W.K., and Wei Q. Thymidylate synthase 5′- and 3′-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck. Clin. Cancer Res. 10 (2004) 7903-7910
40. American Joint Committee on Cancer. Manual for Staging of Cancer. 4th ed. (1988), J.B. Lippincott, Philadelphia
41. Zhao J.H. 2LD, GENECOUNTING and HAP: computer programs for linkage disequilibrium analysis. Bioinformatics 20 (2004) 1325-1326
42. Zapata C., Carollo C., and Rodriguez S. Sampling variance and distribution of the D' measure of overall gametic disequilibrium between multiallelic loci. Ann. Hum. Genet. 65 (2001) 395-406
43. Kietthubthew S., Sriplung H., Au W.W., and Ishida T. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int. J. Hyg. Environ. Health 209 (2006) 21-29
44. Hall J., Hashibe M., Boffetta P., Gaborieau V., Moullan N., Chabrier A., Zaridze D., Shangina O., Szeszenia-Dabrowska N., Mates D., Janout V., Fabianova E., Holcatova I., Hung R.J., McKay J., Canzian F., and Brennan P. The association of sequence variants in DNA repair and cell cycle genes with cancers of the upper aerodigestive tract. Carcinogenesis 28 (2007) 665-671
45. Maki Y., Murakami J., Asaumi J.I., Tsujigiwa H., Nagatsuka H., Kokeguchi S., Fukui K., Kawai N., Yanagi Y., Kuroda M., Tanaka N., Matsubara N., and Kishi K. Role of O(6)-methylguanine-DNA methyltransferase and effect of O(6)-benzylguanine on the anti-tumor activity of cis-diaminedichloroplatinum(II) in oral cancer cell lines. Oral Oncol. 41 (2005) 984-993
46. Krzesniak M., Butkiewicz D., Samojedny A., Chorazy M., and Rusin M. Polymorphisms in TDG and MGMT genes - epidemiological and functional study in lung cancer patients from Poland. Ann. Hum. Genet. 68 (2004) 300-312